BeiGene Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for BeiGene Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/16/2025 | Buy Now | — | Guggenheim | Michael Schmidt51% | — | Reiterates | Buy → Buy | Get Alert |
04/10/2025 | Buy Now | — | Guggenheim | Michael Schmidt51% | $348 → $348 | Reiterates | Buy → Buy | Get Alert |
04/07/2025 | Buy Now | — | RBC Capital | Greg Renza58% | → $312 | Initiates | → Outperform | Get Alert |
02/28/2025 | Buy Now | — | Macquarie | Tony Ren9% | $259 → $313 | Maintains | Outperform | Get Alert |
02/28/2025 | Buy Now | — | Citizens Capital Markets | Matthew Carletti83% | $288 → $348 | Maintains | Market Outperform | Get Alert |
The latest price target for BeiGene (NASDAQ:ONC) was reported by Guggenheim on April 16, 2025. The analyst firm set a price target for $0.00 expecting ONC to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for BeiGene (NASDAQ:ONC) was provided by Guggenheim, and BeiGene reiterated their buy rating.
There is no last upgrade for BeiGene
There is no last downgrade for BeiGene.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BeiGene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BeiGene was filed on April 16, 2025 so you should expect the next rating to be made available sometime around April 16, 2026.
While ratings are subjective and will change, the latest BeiGene (ONC) rating was a reiterated with a price target of $0.00 to $0.00. The current price BeiGene (ONC) is trading at is $229.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.